Alkermes plc. Purchase Commitment, Remaining Minimum Amount Committed
Alkermes plc. (ALKS) had Purchase Commitment, Remaining Minimum Amount Committed of $530.30 million as of 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2019-02-15
- 2018-12-31: Purchase Commitment, Remaining Minimum Amount Committed $530.30M.
- 2017-12-31: Purchase Commitment, Remaining Minimum Amount Committed $473.90M.
- 2016-12-31: Purchase Commitment, Remaining Minimum Amount Committed $432.00M.
- 2015-12-31: Purchase Commitment, Remaining Minimum Amount Committed $399.00M.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2018-12-31 | $530.30M 10-K · filed 2019-02-15 |
| 2017-12-31 | $473.90M 10-K · filed 2018-02-16 |
| 2016-12-31 | $432.00M 10-K · filed 2017-02-17 |
| 2015-12-31 | $399.00M 10-K · filed 2016-02-25 |
| 2014-12-31 | $272.20M 10-K · filed 2015-02-24 |
| 2013-12-31 | $101.80M 10-KT · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |